COVID-19 diagnostics in context.
Adaptive Immunity
Antigens, Viral
/ analysis
Betacoronavirus
/ genetics
COVID-19
Clinical Laboratory Techniques
/ economics
Coronavirus Infections
/ diagnosis
Costs and Cost Analysis
Cross Reactions
Humans
Immunity, Innate
Pandemics
Pneumonia, Viral
/ diagnosis
RNA, Viral
/ analysis
SARS-CoV-2
Serologic Tests
/ methods
Translational Research, Biomedical
United States
/ epidemiology
Viral Load
/ immunology
Journal
Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086
Informations de publication
Date de publication:
03 06 2020
03 06 2020
Historique:
received:
10
04
2020
accepted:
14
05
2020
entrez:
5
6
2020
pubmed:
5
6
2020
medline:
13
6
2020
Statut:
ppublish
Résumé
The coronavirus disease 2019 (COVID-19) pandemic has highlighted the need for different types of diagnostics, comparative validation of new tests, faster approval by federal agencies, and rapid production of test kits to meet global demands. In this Perspective, we discuss the utility and challenges of current diagnostics for COVID-19.
Identifiants
pubmed: 32493791
pii: 12/546/eabc1931
doi: 10.1126/scitranslmed.abc1931
pii:
doi:
Substances chimiques
Antigens, Viral
0
RNA, Viral
0
Types de publication
Comparative Study
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.